摘要
目的:观察盐酸氨溴索预防脑出血患者发生医院内肺炎的效果。方法:选取内科保守治疗,入院时没有肺部感染的脑出血患者,随机分成两组,治疗组在综合治疗基础上应用盐酸氨溴索,对照组不予盐酸氨溴索,其它治疗一样。对照两组患者医院内肺炎发生率。结果:治疗组(应用盐酸氨溴索组)患者医院内肺炎发生率12.8%;对照组(无盐酸氨溴索组)患者医院内肺炎发生率23.2%。结论:盐酸氨溴索预防脑出血患者医院内肺炎安全有效,值得临床应用推广。
Objective:To observe the therapeutic effect of ambroxol in the prevention of nosocomial pneumonia after cerebral hemorrhage. Methods:The inpatients of eerebral hemorrhage treated with conservative therapy without pulmonary infection were selected and randomly divided into two groups. The treating group was given ambroxol on the basis of the comprehensive treatment,the control group was same as the treating group except ambroxol. Then we compared the nosoeomial pneumonia rates of two groups.Results:The nosocomial pneumonia rate of the treatment group and the eontrol group was 12.8% and 23.2% respectively. Concluslon:Application of ambroxol in the prevention of nosoeomial pneumonia after cerebral hemorrhage is safe and effective.It is worth further clinical application.
出处
《现代医药卫生》
2009年第11期1628-1629,共2页
Journal of Modern Medicine & Health
关键词
盐酸氨溴索
脑出血
医院内肺炎
Ambroxol
Cerebral hemorrhage
Nosocomial pneumonia